Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    AGN

No quotes available
-- USD   0.00%
07/23 ADAMIS PHARMACE : Provides Update On License Agreement with Allergan..
07/20 Allergan and Adamas Announce New Expanded Indication for NAMZARIC..
07/20 ALLERGAN : Some of the most inventive medicines, devices, and proced..
SummaryQuotesNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector news 
Latest news on ALLERGAN, INC.
07/23 ADAMIS PHARMACEUTICALS : Provides Update On License Agreement with Allergan plc
07/20 Allergan and Adamas Announce New Expanded Indication for NAMZARIC (Memantine ..
07/20 ALLERGAN : Some of the most inventive medicines, devices, and procedures in the ..
07/20 ALLERGAN : FDA approves expanded label for Namzaric in Alzheimer’s disease
07/20 ALLERGAN : Assigned Patent
07/19 SoftBank bid for ARM catches some hedge funds off guard
07/18 ALLERGAN : Analysts cut Teva price targets
07/17 ALLERGAN : Teva Pharmaceutical Industries Ltd. $40B Deal With Allergan Plc , To ..
07/15 ALLERGAN : Teva readies for Allergan deal with bond sale
07/14 Revance Appoints Industry Leader Julian S. Gangolli to its Board of Directors
07/13 TEVA CEO : Allergan deal to be completed any moment
07/13 BRIEF : Teva shares rise on Allergan deal news
07/13 ALLERGAN : Assigned Patent
07/13 ALLERGAN PLC : Entry into a Material Definitive Agreement, Other Events, Financi..
07/12 Shire on a roll as U.S. approves keenly awaited eye drug
07/10 EXCLUSIVE - WELLCARE, CENTENE MAKE O : sources
07/05 Indian co might buy Teva product lines for $1.5b - report
07/05 How Mayne Pharma's $888 million Eagle landed
07/04 ALLERGAN : A daughter of N.E. Philly sees local opportunities to put capital to ..
07/02 MAYNE PHARMA : back in spotlight with $1bn deal
07/01 MAYNE PHARMA : Pharmas marvellous medicine
07/01 ALLERGAN : Receives Positive Opinion Through European Decentralised Procedure Fo..
06/29 MAYNE PHARMA : to Acquire US Generics Product Portfolio from Teva and Allergan
06/29 ALLERGAN : Global Survey Suggests Women Are Seeking Plastic Surgery as a Confide..
06/28 Teva, Allergan sell product lines to Australian co
06/28 MAYNE PHARMA : expands into US for $889m
06/28 ASTRAZENECA : Announces new antibiotic zavicefta approved in the european union ..
06/23 ALLERGAN : Announces FDA Approval of Supplemental New Drug Application (sNDA) fo..
06/21 ULTRAGENYX PHARMACEUTICAL : Appoints Karah Parschauer as Executive Vice Presiden..
06/21 ALLERGAN : ZYDUS HEALTHCARE BUYS TWO ANDAs FROM TEVA
06/20 ALLERGAN : 1 Stock to Invest in Big Pharma
06/20 ALLERGAN : Ultragenyx Appoints Karah Parschauer as Executive Vice President, Gen..
06/18 Teva sells products to Sagent Pharma to fulfil Allergan Generics deal conditi..
06/16 IRONWOOD PHARMACEUTICALS : and Allergan Announce Supplemental New Drug Applicati..
06/15 ALLERGAN : Assigned Patent
06/15 ALLERGAN : FDA Approves Long-Lasting Juvederm Volbella Dermal Filler, Notes Dr. ..
06/14 ALLERGAN : Local physician assistant's license suspended
06/13 YES BANK : in focus after RBI hikes foreign holding limit
06/13 DR REDDY LABORATORIES : Reddys to buy eight U.S. generic ugs for $350 mn
06/13 Dr Reddys to buy generics portfolio from Teva for US market
06/13 DR REDDY LABORATORIES : India's Dr Reddy's in $350mln deal
06/13 DR REDDY LABORATORIES : In $350-million deal to buy 8 us drugs from teva, allerg..
06/13 ALLERGAN : to Present New Data from its Anti-Infectives Portfolio at ASM Microbe..
06/13 DR REDDY LABORATORIES : to buy eight ANDAs in US for $350 mn
06/12 Dr reddy's to buy product portfolio from teva pharma for $350 million
06/11 DR REDDY LABORATORIES : Reddys to buy eight ANDAs from Teva Pharma for $350 mn
06/11 ALLERGAN : Sale of UMass Lowell-Developed Technology Brings in $3.8M
06/10 ALLERGAN : Study Reveals Gender Differences in Migraine Treatment
06/09 ALLERGAN : Teva stands behind Allergan price
06/09 ALLERGAN : FDA Approves Juvéderm Volbella XC for Use in Lips and Correction of P..
06/07 ALLERGAN : FDA approves Allergan’s hypertension drug Byvalson
06/06 ALLERGAN : Kate Bosworth Partners with Allergan to Celebrate Launch of ACZONE® (..
06/06 ALLERGAN : Announces FDA Approval of BYVALSON™ (nebivolol and valsartan)
06/04 ALLERGAN : Local physician assistant, Statehouse candidate faces lawsuit for adm..
06/03 ALLERGAN : Restraining order issued against Garden City PA for illegal Botox tre..
06/01 ALLERGAN : Stocks retreat on month end
06/01 ALLERGAN : Carl Icahn buys stake in Botox-maker Allergan
06/01 ALLERGAN : Market report
06/01 ALLERGAN : and Medicines360 donate IUDs in response to Puerto Rico Zika outbreak
06/01 ALLERGAN : Carl Icahn buys into Botox with Allergan stake
05/31 Boeing and Medtronic skid, Allergan and Biogen gain ground
05/31 ALLERGAN : Carl Icahn says he bought a stake in Botox-maker Allergan
05/31 CARL ICAHN : Carl Icahn acquires 'large position' in Allergan, backs CEO
05/31 ALLERGAN : Carl Icahn Observing The Rules Of Hedge Fund Friendship
05/26 Anacor received rival bid before Pfizer deal - filing
05/22 TEVA CFO : We'll close Allergan deal next month
05/22 ALLERGAN : Launches 'IBS-D on Tract,' New Online Resource to Support Patients wi..
05/18 ALLERGAN : expansion approved for $13 million city tax deal, awaits $4 million c..
05/17 PFIZER : moves on from Allergan deal collapse with new $5.2bn takeover
05/16 Pfizer buying skin drug maker Anacor for $5.2 billion
05/16 Pfizer to buy eczema drugmaker Anacor for $5.2B
05/16 ALLERGAN : Reinforces Commitment to Hypertension Management with Four Poster Pre..
05/14 TEVA PHARMACEUTICAL : Can Teva Pharmaceutical Industries Ltd (ADR) Survive Gener..
05/14 Baupost took $461 million Allergan stake before Pfizer deal collapsed
05/13 S&P 500 MOVERS : Jwn, nvda
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
Ambrose Robert Douglas Bailey Chairman & President
Scott M. Whitcup Chief Scientific Officer & Executive VP-Research
Raymond H. Diradoorian Executive VP-Global Technical Operations
Maria Teresa Hilado Director
Joann Bradley Investor Relations Contact
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN, INC.13.00%0
JOHNSON & JOHNSON21.72%343 913
PFIZER INC.13.82%222 823
NOVARTIS AG-5.13%219 526
ROCHE HOLDING LTD.-9.62%218 832
MERCK & CO., INC.11.36%162 815
More Results